Braverman.Tiroides_11ed

82 SECCIÓN I n La tiroides normal

189. Chiovato L, Vitti P, Lombardi A, et al. Expression of the micro- somal antigen on the surface of continuously cultured rat thy- roid cells is modulated by thyrotropin. J Clin Endocrinol Metab 1985;61(1):12–16. 190. Zhang X, Arvan P. Cell type-dependent differences in thy- roid peroxidase cell surface expression. J Biol Chem 2000; 275(41):31946–31953. 191. Penel C, Gruffat D, Alquier C, et al. Thyrotropin chronically reg- ulates the pool of thyroperoxidase and its intracellular distribu- tion: a quantitative confocal microscopic study. J Cell Physiol 1998;174(2):160–169. 192. Fayadat L, Niccoli-Sire P, Lanet J, et al. Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic retic- ulum. Its N-glycans are required for folding and intracellular trafficking. Endocrinology 1998;139(10):4277–4285. 193. Fayadat L, Siffroi-Fernandez S, Lanet J, et al. Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the pro- tein. J Biol Chem 2000;275(21):15948–15954. 194. Guo J, McLachlan SM, Hutchison S, et al. The greater glycan con- tent of recombinant human thyroid peroxidase of mammalian than of insect cell origin facilitates purification to homogeneity of enzymatically protein remaining soluble at high concentration. Endocrinology 1998;139(3):999–1005. 195. Nagataki S, UchimuraH,MasuyamaY, et al.Thyrotropin and thy- roidal peroxidase activity. Endocrinology 1973;92(2):363–371. 196. Yamamoto K, DeGroot LJ. Peroxidase and NADPH-cytochrome C reductase activity during thyroid hyperplasia and involution. Endocrinology 1974;95(2):606–612. 197. Nagasaka A, Hidaka H. Quantitative modulation of thyroid iodide peroxidase by thyroid stimulating hormone. Biochem Biophys Res Commun 1980;96(3):1143–1149. 198. Chazenbalk G, Magnusson RP, Rapoport B. Thyrotropin stimu- lation of cultured thyroid cells increases steady state levels of the messenger ribonucleic acid for thyroid peroxidase. Mol Endocri- nol 1987;1(12):913–917. 199. Gerard CM, Lefort A, Libert F, et al. Transcriptional regulation of the thyroperoxydase gene by thyrotropin and forskolin. Mol Cell Endocrinol 1988;60(2–3):239–242. 200. Isozaki O, Kohn LD, Kozak CA, et al. Thyroid peroxidase: rat cDNA sequence, chromosomal localization in mouse, and regu- lation of gene expression by comparison to thyroglobulin in rat FRTL-5 cells. Mol Endocrinol 1989;3(11):1681–1692. 201. Damante G, Chazenbalk G, Russo D, et al. Thyrotropin regu- lation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. Endocrinology 1989;124(6): 2889–2894. 202. Nagayama Y, Yamashita S, Hirayu H, et al. Regulation of thy- roid peroxidase and thyroglobulin gene expression by thyrotro- pin in cultured human thyroid cells. J Clin Endocrinol Metab 1989;68(6):1155–1159. 203. Gerard CM, Lefort A, Christophe D, et al. Control of thyrop- eroxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanisms. Mol Endocrinol 1989;3(12): 2110–2118. 204. Abramowicz MJ, Vassart G, Christophe D. Thyroid peroxidase gene promoter confers TSH responsiveness to heterologous reporter genes in transfection experiments. Biochem Biophys Res Commun 1990;166(3):1257–1264. 205. Aza-Blanc P, Di Lauro R, Santisteban P. Identification of a cis- regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activ- ity. Mol Endocrinol 1993;7(10):1297–1306. 206. Abramowicz MJ, Vassart G, Christophe D. Functional study of the human thyroid peroxidase gene promoter. Eur J Biochem 1992;203(3):467–473.

207. Zannini M, Francis-Lang H, Plachov D, et al. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the rec- ognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol Cell Biol 1992;12(9):4230–4241. 208. Di Palma T, Nitsch R, Mascia A, et al. The paired domain-con- taining factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription. J Biol Chem 2003;278(5):3395–3402. 209. Miccadei S, De Leo R, Zammarchi E, et al. The synergistic activity of thyroid transcription factor 1 and Pax 8 relies on the promoter/ enhancer interplay. Mol Endocrinol 2002;16(4):837–846. 210. Ortiz L, Aza-Blanc P, Zannini M, et al. The interaction between the forkhead thyroid transcription factor TTF-2 and the con- stitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 1999;274(21):15213–15221. 211. De Leo R, Miccadei S, Zammarchi E, et al. Role for p300 in Pax 8 induction of thyroperoxidase gene expression. J Biol Chem 2000;275(44):34100–34105. 212. Kikkawa F, Gonzalez FJ, Kimura S. Characterization of a thyroid- specific enhancer located 5.5 kilobase pairs upstreamof the human thyroid peroxidase gene. Mol Cell Biol 1990;10(12):6216–6224. 213. Mizuno K, Gonzalez FJ, Kimura S.Thyroid-specific enhancer-bind- ing protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1. Mol Cell Biol 1991;11(10):4927–4933. 214. Esposito C, Miccadei S, Saiardi A, et al. PAX 8 activates the enhancer of the human thyroperoxidase gene. Biochem J 1998; 331(Pt 1):37–40. 215. Abramowicz MJ, Targovnik HM, Varela V, et al. Identifica- tion of a mutation in the coding sequence of the human thy- roid peroxidase gene causing congenital goiter. J Clin Invest 1992;90:1200–1204. 216. Bikker H, Vulsma T, Baas F, et al. Identification of five novel inac- tivating mutations in the thyroid peroxidase gene by denaturing gradient gel electrophoresis. Human Mutation 1995;6:9–16. 217. Pannain S, Weiss RE, Jackson CE, et al. Two different mutations in the thyroid peroxidase gene of a large inbred Amish kindred: power and limits of homozygosity mapping. J Clin Endocrinol Metab 1999;84:1061–1071. 218. Bakker B, Bikker H, Vulsma T, et al. Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 2000;85:3708–3712. 219. Ris-Stalpers C, Bikker H. Genetics and phenomics of hypothy- roidism and goiter due to TPO mutations. Mol Cell Endocrinol 2010;322(1–2):38–43. 220. Cavarzere P, Castanet M, Polak M, et al. Clinical description of infants with congenital hypothyroidism and iodide organifica- tion defects. Hormone Res 2008;70(4):240–248. 221. Corvilain B, van Sande J, Laurent E, et al. The H 2 O 2 -generat- ing system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 1991; 128(2):779–785. 222. Song Y, Driessens N, Costa M, et al. Roles of hydrogen perox- ide in thyroid physiology and disease. J Clin Endocrinol Metab 2007;92(10):3764–3773. 223. Ekholm R. Iodination of thyroglobulin. An intracellular or extra- cellular process? Mol Cell Endocrinol 1981;24(2):141–163. 224. Bjorkman U, Ekholm R. Generation of H 2 O 2 in isolated porcine thyroid follicles. Endocrinology 1984;115(1):392–398. 225. Virion A, Michot JL, Deme D, et al. NADPH-dependent H 2 O 2 generation and peroxidase activity in thyroid particular fraction. Mol Cell Endocrinol 1984;36(1–2):95–105. 226. Nakamura Y, Ogihara S, Ohtaki S. Activation by ATP of calcium- dependent NADPH-oxidase generating hydrogen peroxide in thyroid plasma membranes. J Biochem 1987;102(5):1121–1132.

SAMPLE